Oaktree Specialty Lending (OCSL)
(Delayed Data from NSDQ)
$16.41 USD
+0.16 (0.98%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $16.40 -0.01 (-0.06%) 7:32 PM ET
4-Sell of 5 4
D Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.41 USD
+0.16 (0.98%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $16.40 -0.01 (-0.06%) 7:32 PM ET
4-Sell of 5 4
D Value F Growth A Momentum F VGM
Zacks News
Oaktree Specialty Lending (OCSL) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Oaktree Specialty Lending (OCSL) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Oaktree Specialty Lending (OCSL) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) delivered earnings and revenue surprises of -3.51% and 4.41%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Oaktree Specialty Lending (OCSL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Oaktree Specialty Lending (OCSL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Lazard (LAZ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Lazard (LAZ) delivered earnings and revenue surprises of 13.79% and 8.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Oaktree Specialty Lending (OCSL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oaktree Specialty Lending (OCSL) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Oaktree Specialty Lending (OCSL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Oaktree Specialty Lending (OCSL) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) delivered earnings and revenue surprises of -6.56% and 1.51%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Oaktree Specialty Lending (OCSL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Oaktree Specialty Lending (OCSL) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Oaktree Specialty Lending (OCSL) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Oaktree Specialty Lending (OCSL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Oaktree Specialty Lending (OCSL) Q3 Earnings Miss Estimates
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) delivered earnings and revenue surprises of -1.59% and 0.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Merchants Bancorp (MBIN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Merchants Bancorp (MBIN) delivered earnings and revenue surprises of 6.50% and 10.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Oaktree Specialty Lending (OCSL) Meets Q2 Earnings Estimates
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) delivered earnings and revenue surprises of 0% and 4.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Oaktree Specialty Lending (OCSL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Oaktree Specialty Lending (OCSL) stock based on the movements in the options market lately.
Oaktree Specialty Lending (OCSL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) closed at $18.31 in the latest trading session, marking a +1.55% move from the prior day.
Oaktree Specialty Lending (OCSL) Stock Moves -0.27%: What You Should Know
by Zacks Equity Research
In the latest trading session, Oaktree Specialty Lending (OCSL) closed at $18.22, marking a -0.27% move from the previous day.
Oaktree Specialty Lending (OCSL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) delivered earnings and revenue surprises of 10.91% and 3.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Oaktree Specialty Lending (OCSL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Oaktree Specialty Lending (OCSL) closed at $20.38, marking a +1.85% move from the previous day.
Oaktree Specialty Lending (OCSL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oaktree Specialty Lending (OCSL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) closed at $20.09 in the latest trading session, marking a +0.7% move from the prior day.
Oaktree Specialty Lending (OCSL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) closed the most recent trading day at $7.10, moving -0.7% from the previous trading session.
3 Top Stocks With Dividend Yields Above 10%
by Derek Lewis
It's common for companies to up their dividend payouts when business is fruitful, making them enticing investments for income-focused investors from a shorter-term perspective.
Can Oaktree Specialty Lending (OCSL) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Oaktree Specialty Lending (OCSL) Misses Q4 Earnings Estimates
by Zacks Equity Research
Oaktree Specialty Lending (OCSL) delivered earnings and revenue surprises of -5.26% and 5.54%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New York City REIT, Inc. (NYC) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
New York City REIT, Inc. (NYC) delivered FFO and revenue surprises of -180% and 0.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Ahead of Dolby's (DLB) Q4 Earnings Release
by Zacks Equity Research
Dolby Laboratories' (DLB) fourth-quarter performance is likely to have benefited from Dolby Atmos and Dolby Vision. However, inflation and global macroeconomic weakness might have acted as dampeners.